Scarica l'app Stockscreener
71.58
1.22%
-0.945
Arcellx Inc Borsa (ACLX) Ultime notizie
Widening Losses in Q2 and H1 Might Change the Case for Investing in Arcellx (ACLX) - simplywall.st
Evercore ISI Maintains Buy Rating on Arcellx Inc with $115 Price Target - AInvest
Arcellx, Inc. Reports Increased Losses Amid Rising R&D Costs - TipRanks
Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Nektar Therapeutics (NKTR) - The Globe and Mail
Analysts Have Lowered Expectations For Arcellx, Inc. (NASDAQ:ACLX) After Its Latest Results - simplywall.st
We Think Arcellx (NASDAQ:ACLX) Can Afford To Drive Business Growth - uk.finance.yahoo.com
A Quick Look at Today's Ratings for Arcellx(ACLX.US), With a Forecast Between $105 to $134 - 富途牛牛
Long term hold vs stop loss in Arcellx Inc.Free Stable Entry High Return Opportunities - Newser
Can you recover from losses in Arcellx Inc.Fast Return Equity Forecast With Logic - Newser
Using Ichimoku Cloud for Arcellx Inc. technicalsOversold Opportunity Scanner with RSI Data - Newser
Using Bollinger Bands to evaluate Arcellx Inc.Near-Term Market Opportunity Forecast Sheet - Newser
Applying big data sentiment scoring on Arcellx Inc.Secure Buy Strategy Based on Risk Parameters - Newser
Has Arcellx Inc. formed a bullish divergenceFree Weekly Potential Breakout Stock List - Newser
Real time scanner hits for Arcellx Inc. explainedFree Value Investing Picks With Stability - Newser
Historical volatility pattern of Arcellx Inc. visualizedFree Swing Trading Plan With Smart Signals - Newser
Published on: 2025-08-08 23:14:52 - Newser
Arcellx Inc. stock volume spike explainedLoss Limitation Strategy Based on Analysis - Newser
Did Widening Losses and Falling Sales Just Shift Arcellx's (ACLX) Investment Narrative? - simplywall.st
Arcellx 2025 Q2 Earnings Deepened Losses Amid Declining Revenue - AInvest
Does Arcellx Inc. have a sustainable dividendShort-Term Explosive Growth - thegnnews.com
Promising Prospects for Arcellx Inc: Strong Efficacy and Strategic Partnerships Drive Buy Rating - TipRanks
Arcellx shares rise 3.32% intraday after reporting positive Q2 2025 financial results and potential life-changing therapy for multiple myeloma patients. - AInvest
Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights - BioSpace
Promising Outlook for Arcellx Inc.: Buy Rating Backed by Strong Anito-cel Therapy Performance and Favorable Safety Profile - TipRanks
Arcellx earnings beat by $0.08, revenue fell short of estimates - Investing.com Canada
Arcellx Inc: Promising Developments and Strong Clinical Data Drive Buy Rating - TipRanks
Arcellx Inc Shares Dip Amid Revenue Concerns - TipRanks
Arcellx reports Q2 EPS (94c), consensus ($1.03) - TipRanks
Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Arcellx Q2 Revenue Misses Estimates, Adjusted EPS Beats Consensus - AInvest
Earnings Flash (ACLX) Arcellx, Inc. Reports Q2 Revenue $7.6M, vs. FactSet Est of $13.5M - MarketScreener
Arcellx (ACLX) to Release Quarterly Earnings on Thursday - Defense World
Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Why Arcellx Inc. stock attracts strong analyst attentionFree Capital Protection Trading Strategies - Newser
Cantor Fitzgerald Comments on Arcellx FY2025 Earnings - Defense World
Three Stocks Showing Strong Buy Signals - AInvest
Cantor Fitzgerald Upgrades Arcellx (NASDAQ:ACLX) to Strong-Buy - Defense World
Pattern recognition hints at Arcellx Inc. upsideReal-Time Entry Signals for Top Stocks - Newser
Bollinger Band Squeeze Points to Volatility in Arcellx Inc.Scalable Portfolio Growth Suggestions Released - metal.it
Does Arcellx Inc. stock perform well during market downturnsAccelerated profit realization - Jammu Links News
Why is Arcellx Inc. stock attracting strong analyst attentionHigh-profit capital plays - Jammu Links News
Should I hold or sell Arcellx Inc. stock in 2025Invest smarter with data-backed trading alerts - Jammu Links News
What is the dividend policy of Arcellx Inc. stockUnlock exclusive trading strategies for gains - Jammu Links News
What markets is CHEF expanding into Is Arcellx Inc. stock a good long term investment optionBuild a diversified portfolio for steady growth - Jammu Links News
Arcellx (NASDAQ:ACLX) Price Target Raised to $133.00 - Defense World
What analysts say about Arcellx Inc. stockAchieve consistent double-digit growth - Jammu Links News
What is Arcellx Inc. company’s growth strategyUnlock daily market insights for better decisions - Jammu Links News
What catalysts could drive Arcellx Inc. stock higher in 2025Build a portfolio that outperforms the market - Jammu Links News
When is Arcellx Inc. stock expected to show significant growthCapitalize on market momentum for maximum gains - Jammu Links News
Is it the right time to buy Arcellx Inc. stockTremendous gains - Jammu Links News
How does Arcellx Inc. generate profit in a changing economyUnlock steady growth with low-risk stocks - Jammu Links News
Arcellx Inc. Stock Analysis and ForecastExplosive capital gains - Jammu Links News
What is the risk reward ratio of investing in Arcellx Inc. stockMarket-leading profit generation - Jammu Links News
What are Arcellx Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - Jammu Links News
How does Arcellx Inc. compare to its industry peersGet high-impact stock recommendations now - Jammu Links News
How many analysts rate Arcellx Inc. as a “Buy”AI Powered Growth Plan For 2025 - Jammu Links News
Arcellx’s Innovative CAR-T Therapy Study for GMG: A Potential Game-Changer - TipRanks
0.79%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):